Maravai Lifesciences share price today

(MRVI)

Maravai Lifesciences share price is $5.37 & ₹456.32 as on 21 Dec 2024, 2.30 'hrs' IST

$5.37

▲

-0.06

(-1.1%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Maravai Lifesciences share price in Dollar and Rupees. Guide to invest in Maravai Lifesciences from India. Also see the sentimental analysis on Indian investors investing in Maravai Lifesciences. Get details on the Indian mutual funds that are investing in Maravai Lifesciences. Get Analyst recommendations and forecasts along with all the Maravai Lifesciences's financials.

Maravai Lifesciences share price movements

Today's Low: $5.32
Today's High: $5.62
$5.37
0.93%
Downside
Day's Volatility :5.34%
Upside
4.45%
52 Weeks Low: $4.28
52 Weeks High: $11.56
$5.37
20.39%
Downside
52 Weeks Volatility :63.0%
Upside
53.53%

Maravai Lifesciences Returns

Period	Maravai Lifesciences Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-35.3%	-11.1%	0.0%
6 Months	-24.05%	-6.0%	0.0%
1 Year	-18.76%	2.7%	0.0%
3 Years	-86.97%	0.6%	-19.7%

Maravai Lifesciences Key Statistics

in dollars & INR

Previous Close	$5.43
Open	$5.33
Today's High	$5.62
Today's Low	$5.32
Market Capitalization	$1.4B
Today's Volume	$2.3M
52 Week High	$11.555
52 Week Low	$4.275
Revenue TTM	$276.9M
EBITDA	$1.0M
Earnings Per Share (EPS)	$-1.67
Profit Margin	-81.13%
Quarterly Earnings Growth YOY	-0.33%
Return On Equity TTM	-42.93%

How to invest in Maravai Lifesciences from India?

It is very easy for Indian residents to invest directly in Maravai Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Maravai Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Maravai Lifesciences or MRVI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Maravai Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Maravai Lifesciences shares which would translate to 0.158 fractional shares of Maravai Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Maravai Lifesciences, in just a few clicks!

Returns in Maravai Lifesciences for Indian investors in Rupees

Investment Value

₹1,00,000

Maravai Lifesciences investment value today

Current value as on today

₹1,20,955

Returns

₹20,955

(+20.96%)

Returns from Maravai Lifesciences Stock

₹18,759 (false-18.76%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Maravai Lifesciences

55%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Maravai Lifesciences on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 55% more investors are searching Maravai Lifesciences in the last 30 days versus the previous period.

Global Institutional Holdings in Maravai Lifesciences

GTCR LLC
14.21%
12 West Capital Management LP
9.88%
Vanguard Group Inc
8.38%
BlackRock Inc
6.86%
BRAIDWELL LP
5.89%
Mackenzie Investments
4.49%

Analyst Recommendation on Maravai Lifesciences

Buy

78%Buy

21%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Maravai Lifesciences(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Maravai Lifesciences

What analysts predicted

Upside of 68.96%

Current:

$5.37

Target:

$9.07

Insights on Maravai Lifesciences

Price Movement
In the last 3 months, MRVI stock has moved down by -36.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 73.4M → 65.2M (in $), with an average decrease of 11.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.58M → -99.03M (in $), with an average decrease of 1205.7% per quarter
MRVI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 55.1%
MRVI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 110.0%
Price to Sales
ForMRVI every $1 of sales, investors are willing to pay $2.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Maravai Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$123.8M	-
Net Income	$-17.7M	-
Net Profit Margin	-14.32%	-

	FY19	Y/Y Change
Revenue	$143.1M	↑ 15.59%
Net Income	$-5.2M	↓ 70.67%
Net Profit Margin	-3.63%	↑ 10.69%

	FY20	Y/Y Change
Revenue	$284.1M	↑ 98.48%
Net Income	$76.9M	↓ 1578.33%
Net Profit Margin	27.06%	↑ 30.69%

	FY21	Y/Y Change
Revenue	$799.2M	↑ 181.33%
Net Income	$469.3M	↑ 510.3%
Net Profit Margin	58.71%	↑ 31.65%

	FY22	Y/Y Change
Revenue	$883.0M	↑ 10.48%
Net Income	$490.7M	↑ 4.56%
Net Profit Margin	55.57%	↓ 3.14%

	FY23	Y/Y Change
Revenue	$288.9M	↓ 67.28%
Net Income	$-119.0M	↓ 124.26%
Net Profit Margin	-41.19%	↓ 96.76%

	Q2 FY23	Q/Q Change
Revenue	$68.9M	↓ 12.79%
Net Income	$-6.5M	↑ 385.24%
Net Profit Margin	-9.49%	↓ 7.78%

	Q3 FY23	Q/Q Change
Revenue	$66.9M	↓ 2.97%
Net Income	$-6.5M	↓ 1.21%
Net Profit Margin	-9.66%	↓ 0.17%

	Q4 FY23	Q/Q Change
Revenue	$74.1M	↑ 10.88%
Net Income	$-106.0M	↑ 1539.72%
Net Profit Margin	-142.92%	↓ 133.26%

	Q1 FY24	Q/Q Change
Revenue	$64.2M	↓ 13.44%
Net Income	$-12.1M	↓ 88.6%
Net Profit Margin	-18.82%	↑ 124.1%

	Q2 FY24	Q/Q Change
Revenue	$73.4M	↑ 14.37%
Net Income	$-7.6M	↓ 37.2%
Net Profit Margin	-10.33%	↑ 8.49%

	Q3 FY24	Q/Q Change
Revenue	$65.2M	↓ 11.17%
Net Income	$-99.0M	↑ 1205.71%
Net Profit Margin	-151.9%	↓ 141.57%

	FY18	Y/Y Change
Profit	$63.1M	-

	FY19	Y/Y Change
Profit	$76.3M	↑ 20.97%

	FY20	Y/Y Change
Profit	$204.4M	↑ 167.99%

	FY21	Y/Y Change
Profit	$658.7M	↑ 222.17%

	FY22	Y/Y Change
Profit	$714.0M	↑ 8.41%

	FY23	Y/Y Change
Profit	$140.2M	↓ 80.37%

	Q2 FY23	Q/Q Change
Profit	$25.6M	↓ 43.46%

	Q3 FY23	Q/Q Change
Profit	$30.2M	↑ 17.7%

	Q4 FY23	Q/Q Change
Profit	$38.4M	↑ 27.35%

	Q1 FY24	Q/Q Change
Profit	$19.0M	↓ 50.63%

	Q2 FY24	Q/Q Change
Profit	$35.1M	↑ 85.13%

	Q3 FY24	Q/Q Change
Profit	$28.4M	↓ 19.23%

	FY18	Y/Y Change
Operating Cash Flow	$-186.0K	-
Investing Cash Flow	$-3.5M	-
Financing Cash Flow	$-9.2M	-

	FY19	Y/Y Change
Operating Cash Flow	$24.1M	↓ 13065.05%
Investing Cash Flow	$-17.1M	↑ 396.9%
Financing Cash Flow	$-4.2M	↓ 54.54%

	FY20	Y/Y Change
Operating Cash Flow	$152.2M	↑ 531.09%
Investing Cash Flow	$6.1M	↓ 135.39%
Financing Cash Flow	$53.2M	↓ 1376.99%

	FY21	Y/Y Change
Operating Cash Flow	$368.6M	↑ 142.18%
Investing Cash Flow	$105.7M	↑ 1641.18%
Financing Cash Flow	$-159.0M	↓ 398.9%

	FY22	Y/Y Change
Operating Cash Flow	$536.0M	↑ 45.42%
Investing Cash Flow	$-267.6M	↓ 353.29%
Financing Cash Flow	$-187.5M	↑ 17.89%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$19.2M	↓ 77.44%
Investing Cash Flow	$-24.2M	↓ 65.36%
Financing Cash Flow	$-43.1M	↑ 124.55%

Maravai Lifesciences Technicals Summary

Sell

Neutral

Buy

Maravai Lifesciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Maravai Lifesciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Maravai Lifesciences Holdings Inc	8.27%	-24.05%	-18.76%	-86.97%	-85.88%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Maravai Lifesciences Holdings Inc	45.97	NA	NA	-0.08	-0.43	-0.02	NA	2.44
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Maravai Lifesciences Holdings Inc	Buy	$1.4B	-85.88%	45.97	-81.13%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Maravai Lifesciences

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri

Organization	Maravai Lifesciences
Employees	580
CEO	Mr. William E. Martin III
Industry	Commercial Services

Management People of Maravai Lifesciences

Name	Title
Mr. William E. Martin III	CEO & Director
Mr. Kevin M. Herde CPA	Executive VP & CFO
Dr. Peter Michael Leddy Ph.D.	Executive VP & Chief Administrative Officer
Ms. Christine Dolan	Executive VP & GM of Cygnus Technologies
Mr. Andrew Burch	President of Nucleic Acid Production
Mr. Robert Andrew Eckert MBA	Chairman of the Board
Ms. Debra Hart	Senior Director of Investor Relations
Mr. Kurt Oreshack J.D.	Executive VP, General Counsel & Secretary
Ms. Rebecca Buzzeo	Executive VP & Chief Commercial Officer
Dr. Kate E. Broderick Ph.D.	Chief Innovation Officer

Important FAQs about investing in Maravai Lifesciences from India :

What is Maravai Lifesciences share price today?

Maravai Lifesciences share price today stands at $5.37, Open: $5.33 ; Previous Close: $5.43 ; High: $5.62 ; Low: $5.32 ; 52 Week High: $11.56 ; 52 Week Low: $4.28. The stock opens at $5.33, after a previous close of $5.43. The stock reached a daily high of $5.62 and a low of $5.32, with a 52-week high of $11.56 and a 52-week low of $4.28.

Can Indians buy Maravai Lifesciences shares?

Yes, Indians can invest in the Maravai Lifesciences (MRVI) from India.

With INDmoney, you can buy Maravai Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Maravai Lifesciences at zero transaction cost.

How can I buy Maravai Lifesciences shares from India?

It is very easy to buy Maravai Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Maravai Lifesciences be purchased?

Yes, you can buy fractional shares of Maravai Lifesciences with INDmoney app.

What are the documents required to start investing in Maravai Lifesciences stocks?

To start investing in Maravai Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.